搜索结果: 1-8 共查到“肿瘤病理学 Therapy”相关记录8条 . 查询时间(0.147 秒)
Signal Transduction and Targeted Therapy丨柳素玲团队等发现趋化因子CCL20通过重塑肿瘤免疫微环境促进乳腺癌进展的新机制（图）
乳腺癌 肿瘤干细胞 肿瘤恶性 生物医学研究院
2023/4/13
肿瘤微环境（tumor microenvironment，TME）在肿瘤恶性和治疗抵抗中发挥着重要作用。近年来，根据TME特点挖掘潜在靶点并开发安全有效的免疫疗法逐渐成为乳腺癌治疗的研究热点。2018年7月27日，复旦大学生物医学研究院/附属肿瘤医院柳素玲团队在PLOS Biology杂志在线发表了题为CCL20 triggered by chemotherapy hinders the ther...
中南大学基础医学院陶永光和肖德胜团队在国际期刊Signal Transduction and Targeted Therapy上发表研究成果（图）
恶性肿瘤 中南大学基础医学院 病理学 葡萄糖
2023/3/23
近日，中南大学基础医学院 肿瘤研究所研究员陶永光团队与病理学系教授肖德胜团队在国际期刊Signal Transduction and Targeted Therapy（STTT, IF=38.104）发表了题为“GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation ...
近日，中南大学基础医学院病理学系教授肖德胜团队与肿瘤研究所研究员陶永光团队在国际期刊Signal Transduction and Targeted Therapy发表了题为“The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like pro...
A large number of monoclonal antibodies (mAbs) are currently
under investigation for the treatment of malignant diseases. To
date, a significant amount of experimental and clinical research
had bee...
After introducing the dry or nonlactating period of the cows the authors give a survey about the aims of the dry cow therapy. They show the main requirements of dry cow intramammary preparations and t...
RNA combination therapy for lung cancer offers promise for personalized medicine（图）
lung cancer personalized medicine RNA
2014/8/19
Small RNA molecules, including microRNAs (miRNAs) and small interfering RNAs (siRNAs), offer tremendous potential as new therapeutic agents to inhibit cancer-cell growth. However, delivering these sma...
RNA combination therapy for lung cancer offers promise for personalized medicine（图）
lung cancer personalized medicine RNA
2014/8/19
Small RNA molecules, including microRNAs (miRNAs) and small interfering RNAs (siRNAs), offer tremendous potential as new therapeutic agents to inhibit cancer-cell growth. However, delivering these sma...
Gemcitabine- Carboplatin Combination therapy for recurrent ovarian cancer: a prospective study Modares Gilani M
Ovarian cancer recurrence gemcitabin carboplatin survival
2009/12/9
Background: Ovarian cancer is the leading cause of death among all gynecologic cancers in developed countries. The standard treatment for advanced ovarian cancer consists of cytoreductive surgery asso...